Research / VREX / Fundamental state Inspectable configuration
State dimensions Filing 0001681622-25-000015 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
283.78% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.10% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
4.75% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
5.16% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
140.09% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
34.28% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
5.61% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.76% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.05% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 14 states History building
Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 29, 2023 0/8 normalized Level 3 Dec 29, 2023 0/8 normalized Level 3 Mar 29, 2024 0/9 normalized Level 3 Jun 28, 2024 0/9 normalized Level 3 Sep 27, 2024 0/9 normalized Level 3 Jan 3, 2025 0/9 normalized Level 3 Apr 4, 2025 8/9 normalized Level 3 Jul 4, 2025 8/9 normalized Level 3 Oct 3, 2025 8/9 normalized Level 3 Jan 2, 2026 8/9 normalized Level 3 Apr 3, 2026 9/9 normalized Level 3 Jul 3, 2026 9/9 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 54.67%
Current 283.78%
Delta 229.11% Capex Intensity Decreased
Previous 3.32%
Current 2.10%
Delta -1.21% Cash Generation Decreased
Previous 5.83%
Current 4.75%
Delta -1.08% Growth Increased
Previous -9.22%
Current 5.16%
Delta 14.38% Inventory Pressure Increased
Previous 32.65%
Current 140.09%
Delta 107.44% Margin Increased
Previous 31.68%
Current 34.28%
Delta 2.61% Profitability Increased
Previous 3.96%
Current 5.61%
Delta 1.65% R And D Intensity Increased
Previous 10.73%
Current 11.76%
Delta 1.03% Sbc Intensity Increased
Previous 1.89%
Current 2.05%
Delta 0.17% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.